Waters Corporation (WAT)

Currency in USD
352.04
+1.55(+0.44%)
Real-time Data·
WAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
339.15356.99
52 wk Range
275.05414.15
Key Statistics
Prev. Close
350.49
Open
347.76
Day's Range
339.15-356.99
52 wk Range
275.05-414.15
Volume
1.16M
Average Vol. (3m)
1.29M
1-Year Change
-0.1111%
Book Value / Share
155.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
397.32
Upside
+12.86%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Waters Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

13 Buy
9 Hold
0 Sell
Ratings:
22 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 397.32
(+12.86% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy425.00+20.30%400.00MaintainMay 07, 2026
UBS
Hold375.00+6.15%330.00MaintainMay 06, 2026
JPMorgan
Hold345.00-2.34%330.00MaintainMay 06, 2026
Baird
Buy387.00+9.54%362.00MaintainMay 06, 2026
BofA Securities
Hold370.00+4.73%350.00MaintainMay 06, 2026

Waters Corporation SWOT Analysis


Growth Catalysts
Biologics market's 10.3% CAGR through 2028 and GLP-1 treatments' 25%+ growth rate provide tailwinds for Waters' ambitious expansion strategy
Market Dynamics
Waters' expanded portfolio strengthens its competitive edge, with analysts noting a potential upside due to current valuation gap compared to industry peers
Financial Prospects
Projected free cash flow to double by 2027, with adjusted EBITDA margins exceeding 31% and potential for substantial borrowing capacity for future growth
Strategic Expansion
Waters Corporation's acquisition of BDX's Biosciences & Dx business positions it for significant growth in pharmaceutical and biotechnology manufacturing sectors
Read full SWOT analysis

Waters Corporation Earnings Call Summary for Q1/2026

  • Waters posted Q1 2026 EPS of $2.70, beating estimates of $2.31; revenue hit $1.27B vs. $1.20B forecast, driving 10.64% pre-market stock surge to $334.
  • Strong performance driven by successful integration of BD's Biosciences and Diagnostic Solutions acquisition; adjusted operating margin reached 23.6%.
  • CEO Udit Batra highlighted exceptional operational execution and strong positioning for continued growth trajectory and shareholder value delivery.
  • Company faces headwinds including GAAP diluted loss of $(0.87) per share from acquisition charges and Biosciences Division challenges in China market.
  • Management issued optimistic guidance expecting continued revenue and EPS growth, supported by upcoming product launches and strategic expansion initiatives.
Last Updated: 05/05/2026, 10:03 AM
Read Full Transcript
Waters investor slides for Q1/2026
Waters Q1 2026 slides
Last Update: May 05, 2026
See full investor slides

Earnings

Latest Release
May 05, 2026
EPS / Forecast
2.70 / 2.31
Revenue / Forecast
1.27B / 1.2B
EPS Revisions
Last 90 days

WAT Income Statement

Compare WAT to Peers and Sector

Metrics to compare
WAT
Peers
Sector
Relationship
P/E Ratio
77.5x21.5x−0.6x
PEG Ratio
−2.000.360.00
Price / Book
2.3x3.4x2.6x
Price / LTM Sales
9.2x3.0x3.2x
Upside (Analyst Target)
12.5%34.2%48.1%
Fair Value Upside
Unlock12.3%5.8%Unlock

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
47.92M48.81%16.75B
Other Institutional Investors
27.12M27.63%9.48B
Public Companies & Retail Investors
23.13M23.56%8.08B
Total
98.17M100.00%34.31B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Australian Foundation Investment Company Limited12.87%12,634,0004,428,091
BlackRock, Inc.7.78%7,637,2382,676,776

People Also Watch

1,230.21
GWW
-0.32%
395.45
INTU
-2.79%
81.87
ZTS
-6.23%
421.92
SPGI
-1.58%
91.45
NOW
-2.29%

FAQ

What Is the Waters (WAT) Stock Price Today?

The Waters stock price today is 352.04 USD.

What Stock Exchange Does Waters Trade On?

Waters is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Waters?

The stock symbol for Waters is "WAT."

What Is the Waters Market Cap?

As of today, Waters market cap is 34.58B USD.

What Is Waters's Earnings Per Share (TTM)?

The Waters EPS (TTM) is 6.89.

When Is the Next Waters Earnings Date?

Waters will release its next earnings report on Aug 04, 2026.

From a Technical Analysis Perspective, Is WAT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Waters Stock Split?

Waters has split 2 times.

How Many Employees Does Waters Have?

Waters has 16000 employees.

What is the current trading status of Waters (WAT)?

As of May 08, 2026, Waters (WAT) is trading at a price of 352.04 USD, with a previous close of 350.49 USD. The stock has fluctuated within a day range of 339.15 USD to 356.99 USD, while its 52-week range spans from 275.05 USD to 414.15 USD.

What Is Waters (WAT) Price Target According to Analysts?

The average 12-month price target for Waters is 397.32 USD, with a high estimate of 480 USD and a low estimate of 345 USD. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +12.86% Upside potential.

What Is the WAT Premarket Price?

WAT's last pre-market stock price is 349.50 USD. The pre-market share volume is 130.00, and the stock has decreased by -0.99, or -0.28%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.